Abstract
The chelator mercaptoacetyltriglycine (MAG3) forms a single stable chelate with technetium-99m (99mTc) oxotechnetate. The bifunctional N-hydroxysuccinimidyl ester of mercaptoacetyltriglycine with S-acetyl protection of the sulfhydryl group may be used to conjugate MAG3 to primary amine functionalized biomolecules for the purpose of radiolabeling with 99mTc for gamma detection or single photon emission computed tomography imaging (SPECT). We report here an improved MAG3 conjugation and 99mTc radiolabeling method capable of generating high radiochemical yield and high specific radioactivity. Post-labeling purification will not be needed if the protocol is followed as presented. Apart from the preparation of reagents, the conjugation and purification requires about 4 h, while the labeling with 99mTc requires about an additional 30 min.
Your institute does not have access to this article
Relevant articles
Open Access articles citing this article.
-
99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE−/− mice
Scientific Reports Open Access 14 June 2017
-
99mTc-labelled anti-CD11b SPECT/CT imaging allows detection of plaque destabilization tightly linked to inflammation
Scientific Reports Open Access 15 February 2016
Access options
Subscribe to Journal
Get full journal access for 1 year
$119.00
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Lei, K. et al. Technetium-99m antibodies labeled with MAG3 and SHNH-an in vitro and animal in vivo comparison. Nucl. Med. Biol. 23, 917–922 (1996).
Blankenberg, F.G., Vanderheyden, J.L., Strauss, H.W. & Tait, J.F. Radiolabeling of HYNIC–annexin V with technetium-99m for in vivo imaging of apoptosis. Nature Protocols 1, 108–110 (2006).
Welling, M.M. et al. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29–41. Nucl. Med. Biol. 31, 503–509 (2004).
Bogdanov, A., Jr., Tung, C.-H., Bredow, S. & Weissleder, R. DNA binding chelates for nonviral gene delivery imaging. Gene Ther. 8, 515–522 (2001).
Blok, D. et al. New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides. Nucl. Med. Biol. 31, 815–820 (2004).
Liu, G. et al. Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting. Appl. Radiat. Isot. 64, 971–978 (2006).
Fritzberg, A.R., Kasina, S., Eshima, D. & Johnson, D.L. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J. Nucl. Med. 27, 111–116 (1986).
Okarvi, S.M. & Jammaz, I.A. Preparation of in vitro and in vivo evaluation of technetium-(99m)-labeled folate and methotrexate conjugates as tumor imaging agents. Cancer Biother. Radiopharm. 21, 49–60 (2006).
Visser, G.W., Gerretsen, M., Herscheid, J.D., Snow, G.B. & Dongen, G. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol. J. Nucl. Med. 34, 1953–1963 (1993).
Yoo, T.M. et al. Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment. J. Nucl. Med. 38, 294–300 (1997).
Duncan, R.J.S., Weston, P.D. & Wrigglesworth, R. A new reagent which may be used to introduce sulfhydryl-groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132, 68–73 (1983).
Hnatowich, D.J. et al. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine. J. Nucl. Med. 39, 56–64 (1998).
Vanderheyden, J.L. et al. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice. Nucl. Med. Biol. 33, 135–144 (2006).
Winnard, P., Chang, F., Rusckowski, M., Mardirossian, G. & Hnatowich, D.J. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA. Nucl. Med. Biol. 24, 425–432 (1997).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Wang, Y., Liu, G. & Hnatowich, D. Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules. Nat Protoc 1, 1477–1480 (2006). https://doi.org/10.1038/nprot.2006.262
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2006.262
Further reading
-
A Comparison of [99mTc]Duramycin and [99mTc]Annexin V in SPECT/CT Imaging Atherosclerotic Plaques
Molecular Imaging and Biology (2018)
-
99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE−/− mice
Scientific Reports (2017)
-
99mTc-labelled anti-CD11b SPECT/CT imaging allows detection of plaque destabilization tightly linked to inflammation
Scientific Reports (2016)
-
Detection of Klebsiella. Pneumoniae Infection with an Antisense Oligomer Against its Ribosomal RNA
Molecular Imaging and Biology (2016)
-
Optimized Preparation of a 99mTc-Radiolabeled Probe for Tracing MicroRNA
Cell Biochemistry and Biophysics (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.